Friday Sep 12
Global angioedema market: Latest market analysis presented
This report provides elemental information and data relating to the clinical trials on Angioedema. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe.
FDA Approves 2 New Indications For Epaned??, The First And Only...
These indications are in addition to the prior approval for hypertension in patients older than 1 month.1 "Now with 3 indications, Epaned is available to help more patients who need the proven benefits of enalapril in an FDA-approved powder for oral solution, thereby ensuring that they are receiving a medicine that meets the highest quality standards," said Epaned delivers trusted efficacy. The effectiveness of enalapril has been well established in clinical trials.1 With its unique formulation, Epaned provides a consistent potency in each dose.1 Epaned also offers the quality of a product made in accordance with FDA regulations and requirements.